808
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study

, , & | (Reviewing Editor)
Article: 1304873 | Received 30 Sep 2016, Accepted 03 Mar 2017, Published online: 23 Mar 2017

References

  • AIFA Guideline for the classification and conduction of the observational studies on medicines [Internet]. Circular (2010, May 31). Retrieved from https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdf
  • Björnsdóttir, U. S., Gizurarson, S., & Sabale, U. (2013). Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients. International Journal of Clinical Practice, 67, 904–910.10.1111/ijcp.12202
  • Bonini, M., & Usmani, O. S. (2015). The importance of inhaler devices in the treatment of COPD. COPD Research and Practice, 1, 2015.10.1186/s40749-015-0011-0
  • Braido, F., Baiardini, I., Sumberesi, M., Blasi, F., & Canonica, G. W. (2013). Obstructive lung diseases and inhaler treatment: Results from a national public pragmatic survey. Respiratory Research, 14, 94.10.1186/1465-9921-14-94
  • Braido, F., Lavorini, F., Blasi, F., Baiardini, I., & Canonica, G. W. (2015). Switching treatments in COPD: Implications for costs and treatment adherence. International Journal of Chronic Obstructive Pulmonary Disease, 10, 2601–2608.10.2147/COPD
  • Bryant, J., McDonald, V. M., Boyes, A., Sanson-Fisher, R., Paul, C., & Melville, J. (2013). Improving medication adherence in chronic obstructive pulmonary disease: A systematic review. Respiratory Research, 14, 109.10.1186/1465-9921-14-109
  • Doyle, S., Lloyd, A., Williams, A., Chrystyn, H., Moffat, M., Thomas, M., … Priced, D. (2010). What happens to patients who have their asthma device switched without their consent? Primary Care Respiratory Journal General Practice Airways Group, 19, 131–139.
  • European Respiratory Society. (2013). European lung white book [Internet]. Retrieved from http://www.erswhitebook.org/
  • Gibson, G. J., Loddenkemper, R., Lundbäck, B., & Sibille, Y. (2013). Respiratory health and disease in Europe: The new European Lung White Book. European Respiratory Journal, 42, 559–563.10.1183/09031936.00105513
  • Global Strategy for the Diagnosis, Management and Prevention 10 of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Internet]. (2016). Retrieved from http://www.goldcopd.org/
  • Herse, F., Kiljander, T., & Lehtimäki, L. (2015). Annual costs of chronic obstructive pulmonary disease in Finland during 1996–2006 and a prediction model for 2007–2030. NPJ Primary Care Respiratory Medicine, 25, 331.10.1038/npjpcrm.2015.15
  • Larsson, K., Janson, C., Lisspers, K., Jørgensen, L., Stratelis, G., Telg, G., … Johansson, G. (2013). Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: The PATHOS study. Journal of Internal Medicine, 273, 584–594.10.1111/joim.2013.273.issue-6
  • Laube, B. L., Janssens, H. M., de Jongh, F. H., Devadason, S. G., Dhand, R., Diot, P., … Chrystyn, H. (2011). What the pulmonary specialist should know about the new inhalation therapies. European Respiratory Society; International Society for Aerosols in Medicine, 37, 1308–1417.10.1183/09031936.00166410
  • Lavorini, F., Braido, F., Baiardini, I., Blasi, F., & Canonica, G. W. (2015). Asthma and COPD: Interchangeable use of inhalers. A document of Italian society of allergy, asthma and clinical immunology (SIAAIC) & Italian society of respiratory medicine (SIMeR). Pulmonary Pharmacology & Therapeutics, 34, 25–30.10.1016/j.pupt.2015.07.005
  • Mäkelä, M. J., Backer, V., Hedegaard, M., & Larsson, K. (2013). Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respiratory Medicine, 107, 1481–1490.10.1016/j.rmed.2013.04.005
  • Melani, A. S., & Paleari, D. (2016). Maintaining control of chronic obstructive airway disease: Adherence to inhaled therapy and risks and benefits of switching devices. COPD: Journal of Chronic Obstructive Pulmonary Disease, 13, 241–250.10.3109/15412555.2015.1045972
  • Ministry of Labour, Health and Social Policies. Annual report on the hospitalization activity [Internet]. (2005). Retrieved from http://www.ministerosalute.it/programmazione/sdo/sezDocumenti.jsp?id=148&label=osp
  • Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., … Soriano, J. B. (2013). A new approach to grading and treating COPD based on clinical phenotypes: Summary of the Spanish COPD guidelines (GesEPOC). Primary Care Respiratory Journal, 22, 117–121.10.4104/pcrj.2013.00016
  • Qaseem, A., Wilt, T. J., Weinberger, S. E., Hanania, N. A., Criner, G., van der Molen, T., … MacDonald, R. (2011). Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American college of physicians, American college of chest physicians, American thoracic society, and European respiratory society. Annals of Internal Medicine, 155, 179–191.10.7326/0003-4819-155-3-201108020-00008
  • Raluy-Callado, M., Lambrelli, D., MacLachlan, S., & Khalid, J. M. (2015). Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. International Journal of Chronic Obstructive Pulmonary Disease, 10, 925–937.10.2147/COPD
  • Sanduzzi, A., Balbo, P., Candoli, P., Catapano, G. A., Contini, P., Mattei, A., … Stanziola, A. A. (2016). COPD: Adherence to therapy. Multidisciplinary Respiratory Medicine, 11, 4.
  • Virchow J. C., Akdis C. A., Darba J., Dekhuijzen R., Hartl S., Kobelt G., … Torvinen, S. (2015). A review of the value of innovation in inhalers for COPD and asthma. Journal of Market Access & Health Policy, 3.
  • World Health Organization (WHO). Global Health Observatory (GHO) data. Chronic respiratory diseases [Internet]. (2016). Retrieved from http://www.who.int/gho/ncd/mortality_morbidity/chronic_respiratory_diseases/en/
  • Wurst, K., St Laurent, S., Muellerova, H., & Davis, K. (2014). Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: A retrospective cohort study. International Journal of Chronic Obstructive Pulmonary Disease, 9, 1021–1031.10.2147/COPD
  • Yawn, B. P. (2011). Optimizing chronic obstructive pulmonary disease management in primary care. Southern Medical Journal, 104, 121–127.